SEGMENT INFORMATION AND GEOGRAPHIES (Tables)

12 Months Ended

Jul. 31, 2013

Segment Reporting [Abstract]

Segment Information

SEGMENT INFORMATION:	2013		2012		2011
SALES:
Life Sciences	$	1,309,375	$	1,253,594	$	1,184,142
Industrial	1,338,688		1,418,062		1,333,053
Total	$	2,648,063	$	2,671,656	$	2,517,195
SEGMENT PROFIT:
Life Sciences	319,271		319,312		292,503
Industrial	214,798		198,747		182,749
Total segment profit	534,069		518,059		475,252
Corporate Services Group	66,640		64,114		61,125
ROTC	40,182		66,858		26,505
Interest expense, net	15,621		20,177		18,903
Earnings before income taxes from continuing operations	$	411,626	$	366,910	$	368,719
DEPRECIATION AND AMORTIZATION:
Life Sciences	$	61,709	$	55,489	$	47,895
Industrial	42,641		45,419		38,585
Subtotal	104,350		100,908		86,480
Corporate Services Group	1,934		2,479		2,239
Total depreciation and amortization from continuing operations	$	106,284	$	103,387	$	88,719
CAPITAL EXPENDITURES:
Life Sciences	$	40,589	$	47,694	$	55,313
Industrial	33,551		26,227		41,361
Subtotal	74,140		73,921		96,674
Corporate/Shared Services Groups	36,042		84,988		64,097
Total	$	110,182	$	158,909	$	160,771
IDENTIFIABLE ASSETS:
Life Sciences	$	1,090,585	$	1,274,036	$	1,097,616
Industrial	898,064		955,541		1,011,778
Subtotal	1,988,649		2,229,577		2,109,394
Corporate/Shared Services Groups	1,484,190		1,118,315		1,123,022
Total	$	3,472,839	$	3,347,892	$	3,232,416
GEOGRAPHIC INFORMATION:
SALES:
Americas	$	849,486	$	839,984	$	779,763
Europe	1,034,515		1,022,952		995,521
Asia	764,062		808,720		741,911
Total	$	2,648,063	$	2,671,656	$	2,517,195

SEGMENT INFORMATION:	2013			2012			2011
IDENTIFIABLE ASSETS:
Americas	$	1,127,364		$	1,318,312		$	1,108,943
Europe	590,893			644,721			695,297
Asia	322,483			350,510			375,283
Eliminations	(52,091		)	(83,966		)	(70,129		)
Subtotal	1,988,649			2,229,577			2,109,394
Corporate/Shared Services Groups	1,484,190			1,118,315			1,123,022
Total	$	3,472,839		$	3,347,892		$	3,232,416

S